Supreme Court Summons Baba Ramdev and Acharya Balkrishna Over Contempt Notice Ignored
In February, the court strongly criticized Patanjali, saying that the company’s ads misled the whole country.
In New Delhi, the Supreme Court has summoned Patanjali Ayurveda’s managing director, Acharya Balkrishna, and yoga guru Baba Ramdev to attend the next hearing regarding the case of misleading advertisements. The court’s decision came after the company failed to reply to the contempt notice.
The court also sent a notice to Baba Ramdev, asking him to explain why contempt proceedings should not be started against him.
In February, the court strongly criticized advertisements for herbal products that claim to cure diseases, saying they misled the entire country.
The court had sent a notice to Patanjali Ayurved and its managing director, Acharya Balkrishna, asking why they shouldn’t face contempt proceedings for apparently breaking their promise made in court regarding the advertising of their products and their effectiveness.
The court also told the company and its officers not to speak publicly against any medical systems.
The court had inquired about the actions taken by the Centre against Patanjali Ayurveda for its advertisements claiming that its medicines can cure various diseases, which were allegedly incorrect and misleading.
The Indian Medical Association (IMA) has gone to court against the company started by Baba Ramdev, claiming that they’ve been running a campaign to discredit modern medicine.
On November 21 of the previous year, the company promised the court that they would not break any laws, especially regarding advertising or branding their products. They also pledged not to make any statements to the media claiming medical effectiveness or criticizing any medical system.
This happened after the court warned the company not to make untrue or misleading claims in its medicine advertisements.
Last month, the court stopped Patanjali Ayurved from advertising or branding products meant to treat conditions listed as diseases, disorders, or conditions in the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.